Currently out of the existing stock ratings of Paul Ginocchio, 12 are a HOLD (25%), 36 are a BUY (75%).

Paul Ginocchio

Work Performance Price Targets & Ratings Chart

Analyst Paul Ginocchio, currently employed carries an average stock price target met ratio of 95.83% that have a potential upside of 24.21% achieved within 346 days. Previously, Paul Ginocchio worked at DEUTSCHE BANK.

Paul Ginocchio’s has documented 64 price targets and ratings displayed on 6 stocks. The coverage was on the Industrials sector.

Most recent stock forecast was given on EFX, Equifax at 12-Feb-2016.

Wall Street Analyst Paul Ginocchio

Analyst best performing recommendations are on TBI (TRUEBLUE).
The best stock recommendation documented was for TBI (TRUEBLUE) at 10/16/2015. The price target of $26 was fulfilled within 6 days with a profit of $3.56 (15.86%) receiving and performance score of 26.44.

Average potential price target upside

EFX Equifax MAN ManpowerGroup TBI TrueBlue VRSK Verisk Analytics ASGN ASGN RHI Robert Half International

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$320

$61.57 (23.82%)

$271

10 days ago
(12-Dec-2024)

31/33 (93.94%)

$53.27 (19.97%)

154

Buy

$284

$25.57 (9.89%)

$305

1 months 2 days ago
(20-Nov-2024)

15/16 (93.75%)

$42.47 (17.58%)

207

Buy

$350

$91.57 (35.43%)

$350

1 months 24 days ago
(28-Oct-2024)

14/18 (77.78%)

$79.98 (29.62%)

266

Buy

$333

$74.57 (28.86%)

$290

2 months 4 days ago
(18-Oct-2024)

14/15 (93.33%)

$51.01 (18.09%)

283

Buy

$360

$101.57 (39.30%)

$250

2 months 21 days ago
(01-Oct-2024)

10/11 (90.91%)

$69.74 (24.03%)

255

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Paul Ginocchio?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?